Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

Geopolitical tensions are escalating to levels not seen in decades, global trade relationships face unprecedented strain, and ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

The global endoscopic ultrasonography market, valued at US$1.28 billion in 2023, is forecasted to grow at a robust CAGR of ...

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients: Galway, Ireland Tuesday, April 1 ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

STEUBENVILLE — Research suggests that exercise can be beneficial for individuals who suffer from Parkinson’s Disease, a ...